NEW YORK (GenomeWeb) — CancerLinQ has entered into an agreement with Tempus and Precision HealthAI to accelerate development and delivery of high-quality, deidentified clinical databases, CancerLinQ said yesterday.

The databases are intended for use by CancerLinQ, a non-profit subsidiary of the American Society of Clinical Oncology, as well as its oncologist subscribers, partners, and the broader cancer community. They will be made available through the core CancerLinQ quality improvement platform and the organization's CancerLinQ Discovery service.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York City medical examiner is overseeing an effort to identify missing persons using DNA, according to the Associated Press.

Nobel laureate Günter Blobel has died at 81, the New York Times reports.

In PNAS this week: mouse model of genetically induced emphysema, gene expression signatures of circulating melanoma cells, and more.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

Mar
13
Sponsored by
Agilent

This webinar will share how clinical genetics labs can integrate cytogenetics and molecular data to assess abnormalities using a single sample on a single workflow platform.